000 | 01949 a2200529 4500 | ||
---|---|---|---|
005 | 20250515051913.0 | ||
264 | 0 | _c20070321 | |
008 | 200703s 0 0 eng d | ||
022 | _a1567-5769 | ||
024 | 7 |
_a10.1016/j.intimp.2006.09.021 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTalmadge, James E | |
245 | 0 | 0 |
_aChemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion. _h[electronic resource] |
260 |
_bInternational immunopharmacology _cFeb 2007 |
||
300 |
_a140-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a1,2-Dimethylhydrazine |
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticarcinogenic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArginase _xgenetics |
650 | 0 | 4 |
_aBreast Neoplasms _ximmunology |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aCarcinogens |
650 | 0 | 4 | _aCelecoxib |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aConcanavalin A _xpharmacology |
650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aIntestinal Neoplasms _xchemically induced |
650 | 0 | 4 |
_aMembrane Proteins _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
650 | 0 | 4 |
_aPyrazoles _xtherapeutic use |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aSpleen _xcytology |
650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
700 | 1 | _aHood, Keith C | |
700 | 1 | _aZobel, Lori C | |
700 | 1 | _aShafer, Laura R | |
700 | 1 | _aColes, Melissa | |
700 | 1 | _aToth, Bela | |
773 | 0 |
_tInternational immunopharmacology _gvol. 7 _gno. 2 _gp. 140-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2006.09.021 _zAvailable from publisher's website |
999 |
_c16746183 _d16746183 |